The primary side effect reported with GLP-1 patches is often a failure to lose weight, which can potentially delay medical care for obesity and cause psychological harm from false hope
Talking With Patients About Alcohol and GLP1s Effective patient communication is essential when discussing GLP-1 alcohol use reduction
It's important to note that while large clinical trials and regulatory reviews have not found a causal link between GLP-1 RAs and increased risk of depression or suicidal thoughts, individual experiences can vary
Patients with type 2 diabetes and central obesity particularly benefit, though contraindications include personal or family history of medullary thyroid carcinoma
So let's get into what the weight loss looked like in this first trial, because there are longer obesity trials where, where the primary outcome is the weight loss this was again a specific trial in measuring pain reduction in folks with osteoarthritis of the knee but check out these numbers these are placebo adjusted meaning it's taking the two percent out that people lost on placebo but looking at these numbers Folks on one milligram over forty eight weeks lost seventeen percent
The idea comes from the fact that drugs used to treat diabetes lower blood sugar
